Jump to a page, ticker, or person
Administrator · OGE filing disclosures
Estimated from OGE financial disclosure transaction ranges. Values are midpoints of reported ranges. Purchases add exposure, sales reduce it.
All disclosed activity and performance.
Est. net exposure
~$0
-$28K – $28K
Buys · Sells
Total transactions
4
Latest filing Nov 18, 2025
Performance vs S&P 500
—
No priced purchases yet to compare against the index.
Activity timeline
Estimated purchase vs sale volume by month. Values are midpoints of OGE ranges.
Estimated from OGE-disclosed value ranges (we use range midpoints). Purchases raise estimated exposure; sales lower it. Reported transactions don't prove an asset is still held — this isn't a live brokerage portfolio. Stocks & ETFs give the best basis for rough portfolio percentages and performance; bonds are debt exposure and aren't return-tracked.
4 transactions
Showing 1–4 of 4 transactions
| Date | Company | Sector | Type | Amount | Exec. Price | Return |
|---|---|---|---|---|---|---|
Aug 1, 2025• | NRSNNeuroSense Therapeutics Ltd. Ordinary SharesStock | — | Purchase | ~$1K – $15K | — | — |
May 16, 2025 | DVLTDatavaultStock | — | Sale | ~$1K – $15K | — | — |
May 13, 2025 | DVLTDatavaultStock | — | Purchase | ~$1K – $15K | — | — |
May 13, 2025 | NRSNNeuroSense Therapeutics Ltd. Ordinary SharesStock | — | Sale | ~$1K – $15K | — | — |